SCHEMBL7220953

SCHEMBL7220953

O=C(O)c1ccc(OCC(=O)N2CCN(Cc3ccc(Cl)cc3)CC2)c(Cl)c1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.54
KDM4E B2RXH2 3/20 0.54
ALDH1A1 P00352 1/20 0.54
CCR1 P32246 1/20 0.54
LMNA P02545 5/20 0.53
POLB P06746 2/20 0.53
CYP3A4 P08684 2/20 0.53
ABCB11 O95342 1/20 0.53
CYP1A2 P05177 1/20 0.53
ADRA2A P08913 1/20 0.53
CYP2D6 P10635 1/20 0.53
CHRM1 P11229 1/20 0.53
TBXA2R P21731 1/20 0.53
SLC6A2 P23975 1/20 0.53
SLC6A4 P31645 1/20 0.53
CYP2C19 P33261 1/20 0.53
ADRA1A P35348 1/20 0.53
OPRM1 P35372 1/20 0.53
DRD3 P35462 1/20 0.53
SLC6A3 Q01959 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5063854 0.87 LMNA (0.59) SMN1; SMN2KDM4EALDH1A1CCR1LMNA
SCHEMBL5064131 0.87 CCR1 (0.60) SMN1; SMN2KDM4EALDH1A1CCR1LMNA
SCHEMBL5061693 0.87 CCR1 (0.57) SMN1; SMN2KDM4EALDH1A1CCR1LMNA
SCHEMBL5064539 0.85 SMN1; SMN2 (0.56) SMN1; SMN2KDM4EALDH1A1CCR1LMNA
SCHEMBL5055981 0.85 LMNA (0.60) SMN1; SMN2KDM4EALDH1A1CCR1LMNA
SCHEMBL5055612 0.84 LMNA (0.56) SMN1; SMN2KDM4EALDH1A1CCR1LMNA
SCHEMBL5059487 0.84 POLB (0.57) SMN1; SMN2KDM4EALDH1A1CCR1LMNA
SCHEMBL5064464 0.84 CCR1 (0.56) SMN1; SMN2KDM4EALDH1A1CCR1LMNA
SCHEMBL5055442 0.84 CCR1 (0.54) SMN1; SMN2KDM4EALDH1A1CCR1LMNA
SCHEMBL5059188 0.84 CCR1 (0.54) SMN1; SMN2KDM4EALDH1A1CCR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6541476-B1 Treating multiple sclerosis or encephalomyelitis in a human SCHERING AKTIENGESELLSCHAFT (DE) 2003-04-01 US disclosed